Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Cohen Cheryl, Directeur. Director active across 2 companies, notably Aerpio Pharmaceuticals, Inc.. Cumulatively, 5 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €1.6m. Activity tracked since 30 June 2021. The latest transaction was disclosed on 2 July 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Cheryl Cohen is a Director at Aerpio Pharmaceuticals, Inc. and ImmunityBio, Inc. She plays a key role in the strategic direction of these companies, bringing her expertise to guide development and growth initiatives.